Fri Jul 28, 2023 – 3:31 pm EDT
(LifeSiteNews) – mRNA technology pioneer Dr. Robert Malone participated Thursday in the White Coat Summit hosted by America’s Frontline Doctors, during which he laid out information and analysis concerning the “good, the bad, and the ugly” of genetic vaccine technology.
Malone, a prominent critic of the government and medical establishment’s response to the COVID-19 outbreak, summarized the rollout of the mRNA-based COVID vaccines as the “deployment of gene therapy for the purpose of eliciting a vaccine response,” and while the application gene therapy technology (of which mRNA technology is a subset) to vaccines holds great potential, the way the authorities went about it was nothing short of disastrous.
Conventional clinical trials for vaccines historically take about a decade, he explained, and can cost $10,000 to $20,000 per patient, and require careful monitoring of tens of thousands of vaccinated subjects in order to identify adverse reactions. What’s more, separate manufacturing facilities must be constructed for each different vaccine, further exacerbating costs.
In theory, Malone said, applying gene therapy technology to vaccines could mitigate the latter consideration by allowing the same manufacturing processes to be used to make a variety
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors